Quick Comparison

ALCARSulbutiamine
Half-Life4-5 hours5 hours
Typical DosageStandard: 500-2000 mg daily in 1-2 doses. For cognitive support: 1000-2000 mg daily. For neuropathy: 1500-3000 mg daily. Take in the morning — may be mildly stimulating.Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently.
AdministrationOral (capsules, powder). Well-absorbed on an empty stomach.Oral (capsules, tablets). Fat-soluble — take with food.
Research Papers9 papers10 papers
Categories

Mechanism of Action

ALCAR

ALCAR crosses the blood-brain barrier via the organic cation transporter (OCTN2) more effectively than L-carnitine. In neurons, it is hydrolyzed by carnitine acetyltransferase to donate its acetyl group to coenzyme A, forming acetyl-CoA—which can then be used for acetylcholine synthesis via choline acetyltransferase, effectively providing raw material for the memory neurotransmitter. ALCAR also transports long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase system for beta-oxidation and ATP production. ALCAR activates nerve growth factor (NGF) signaling, possibly through modulation of NGF receptor (TrkA) expression or downstream MAPK/ERK pathways. It has antioxidant properties, reducing lipid peroxidation in mitochondrial membranes and scavenging free radicals. These mechanisms support cognitive function and neuroprotection.

Sulbutiamine

Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.

Risks & Safety

ALCAR

Common

Nausea, fishy body odor, restlessness, gastrointestinal discomfort.

Serious

May increase agitation in Alzheimer's patients. TMAO production may be a cardiovascular concern with chronic high doses.

Rare

Seizures in susceptible individuals, increased thyroid activity.

Sulbutiamine

Common

Headache, insomnia, irritability, nausea. Tolerance develops with daily use.

Serious

No serious adverse effects documented.

Rare

Skin rash, mood instability, agitation.

Full Profiles